These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36206100)
1. LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p/ YAP1 axis. Tian T; Luo B; Shen G; Ji G Anticancer Drugs; 2022 Nov; 33(10):1012-1023. PubMed ID: 36206100 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression. Ma Y; Jin Y; Li C; Liu Y; Wang D Exp Dermatol; 2021 Dec; 30(12):1764-1774. PubMed ID: 34218464 [TBL] [Abstract][Full Text] [Related]
5. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis. Sun Y; Wang P; Yang W; Shan Y; Zhang Q; Wu H Cancer Biol Ther; 2019; 20(6):729-739. PubMed ID: 30915884 [TBL] [Abstract][Full Text] [Related]
6. Wan N; Yang W; Cheng H; Wang J Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225 [No Abstract] [Full Text] [Related]
7. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278 [TBL] [Abstract][Full Text] [Related]
8. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis. Cai T; Peng B; Hu J; He Y Bioengineered; 2022 May; 13(5):13407-13421. PubMed ID: 36700475 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
11. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis. Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440 [TBL] [Abstract][Full Text] [Related]
12. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis. Duan H; Li X; Chen Y; Wang Y; Li Z Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis. Yan F; Ma Y; Liu L; Li L; Deng J; Sun J J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404 [TBL] [Abstract][Full Text] [Related]
14. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis. Lu YH; He DS; Li Y; Wang H; Ma RD Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1. Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426 [TBL] [Abstract][Full Text] [Related]
16. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2. Chen X; Gao J; Yu Y; Zhao Z; Pan Y Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886 [TBL] [Abstract][Full Text] [Related]
17. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related]
18. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells. Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997 [TBL] [Abstract][Full Text] [Related]
19. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis. Zhang L; Zhao Y; Guan H; Zhang D Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521 [TBL] [Abstract][Full Text] [Related]
20. LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis. Liu S; Wang X; Zhang J; Liu Y; Li B Turk J Gastroenterol; 2023 May; 34(5):497-507. PubMed ID: 36620931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]